ACTG, a global clinical trials network focused on HIV and other infectious diseases, today presented data demonstrating that switching to an integrase inhibitor-based antiretroviral regimen increased ...
In the trials, omalizumab and multi-allergen oral immunotherapy showed alike efficacy in protecting against food allergies, ...
Scientists have discovered a strategy to fight back against norovirus, a leading cause of gastroenteritis worldwide. Their new study identifies powerful antibodies capable of neutralizing a wide range ...
News Medical on MSN1d
HPTN 094 study examines a novel way to take addiction care and HIV prevention to people who inject drugsResearchers from the HIV Prevention Trials Network (HPTN) presented results from the HPTN 094 (“INTEGRA”) study at the 2025 ...
Tecovirimat is Safe but Not Efficacious in People with Clade II Mpox Today's presentation, which was highlighted in a CROI press conference, found that tecovirimat did not reduce the time to clinical ...
To learn more, please visit www.reprievetrial.org.
Eron, M.D., University of North Carolina ... It is sponsored by the National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID, which also funds ACTG) under ...
Alpha-gal syndrome (AGS) is a severe tick-vectored food allergy caused by sensitivity to the galactose-alpha-1,3-galactose ...
Vaccines. Fluoride. Autism. Communications involving these and 20 other “controversial, high profile, or sensitive” topics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback